Complications of thrombolytic therapy
- 30 April 1995
- journal article
- Published by Elsevier in Fibrinolysis
- Vol. 9, 78-80
- https://doi.org/10.1016/s0268-9499(08)80017-3
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Pre-dosing antibody levels and efficacy of thrombolytic drugs containing streptokinase.Heart, 1994
- Individual risk assessment for intracranial haemorrhage during thrombolytic therapyThe Lancet, 1993
- An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- Prevention and management of bleeding complications after thrombolysisInternational Journal of Cardiology, 1993
- Intracerebral haemorrhage after thrombolytic therapy for acute myocardial infarctionPublished by Oxford University Press (OUP) ,1992
- Intracranial hemorrhage in association with thrombolytic therapy: Incidence and clinical predictive factorsJournal of the American College of Cardiology, 1992
- Differential effects of aprotinin and tranexamic acid on cerebral bleeding and cutaneous bleeding time during rt-PA infusionThrombosis Research, 1991
- Correlation between template bleeding times and spontaneous bleeding during treatment of acute myocardial infarction with recombinant tissue-type plasminogen activator.Circulation, 1989
- Thrombolysis in myocardial infarction (TIMI) trial—Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinaseJournal of the American College of Cardiology, 1988